Literature DB >> 11174350

Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease.

A L Ribeiro1, R S Moraes, J P Ribeiro, E L Ferlin, R M Torres, E Oliveira, M O Rocha.   

Abstract

BACKGROUND: Parasympathetic dysautonomia is an established feature of advanced Chagas cardiomyopathy. However, in the absence of cardiac involvement, the presence of vagal dysfunction remains controversial. In a cross-sectional study, we compared patients with Chagas disease without cardiac involvement and healthy individuals by three different methods to determine whether vagal dysfunction is present in the early phase of Chagas disease.
METHODS: Sixty-one patients with Chagas disease without cardiac involvement and 38 controls were submitted to respiratory sinus arrhythmia test and 24-hour Holter monitoring. Vagal heart influences were assessed by the expiratory/inspiratory (E/I) ratio, time-domain indexes of heart rate variability (HRV), and by the quantification of a 3-dimensional return map.
RESULTS: The two groups were comparable in terms of left ventricular ejection fraction and left ventricular end-diastolic dimension. Compared with the control group, patients with Chagas disease had significantly lower values of the E/I ratio (mean +/- SD: 1.38 +/- 0.02 and 1.25 +/- 0.02, P <.004) and short-term indexes of HRV (median [interquartile range]-rMSSD: 23 [18-27] and 17 [13-23], P =.00; pNN50: 11 [7-17] and 6 [2-12], P =.00). P(3), a beat-to-beat HRV index derived from the 3-dimensional return map, also was significantly reduced in the Chagas disease group (mean +/- SD: 118 +/- 5 vs 100 +/- 4, P =.00). None of these indexes of vagal heart control were significantly correlated with left ventricular function or to the presence of esophageal radiologic abnormalities.
CONCLUSION: Parasympathetic dysautonomia is an independent and early phenomenon in Chagas disease and may precede left ventricular systolic dysfunction.

Entities:  

Mesh:

Year:  2001        PMID: 11174350     DOI: 10.1067/mhj.2001.111406

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  22 in total

1.  Abnormalities in fractal heart rate dynamics in Chagas disease.

Authors:  Marcos Roberto de Sousa; Heikki V Huikuri; Federico Lombardi; Amanda A Perez; Murilo E D Gomes; Marcio Vinícius Lins Barros; Vladimir Costa Val Barros; Manoel Otávio Costa Rocha; Antonio Luiz Pinho Ribeiro
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-04       Impact factor: 1.468

2.  Enhanced parasympathetic activity in Chagas disease still stands in need of proof.

Authors:  Antonio Luiz P Ribeiro; Antonio Carlos Campos de Carvalho; Federico Lombardi; Mauro Martins Teixeira; Manoel Otávio Costa Rocha
Journal:  Int J Cardiol       Date:  2008-07-03       Impact factor: 4.164

3.  Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects.

Authors:  A C Nóbrega; A F dos Reis; R S Moraes; B G Bastos; E L Ferlin; J P Ribeiro
Journal:  Clin Auton Res       Date:  2001-02       Impact factor: 4.435

Review 4.  The Valsalva maneuver in Chagas disease patients without cardiopathy.

Authors:  Antonio L P Ribeiro; Marcos Soares Campos; Leonardo Matos Gomes Baptista; Marcos R de Sousa
Journal:  Clin Auton Res       Date:  2009-11-26       Impact factor: 4.435

5.  Small fiber neuropathy in the chronic phase of Chagas disease: a case report.

Authors:  Maria Nolano; V Provitera; F Manganelli; A Pagano; A Perretti; L Santoro
Journal:  Clin Auton Res       Date:  2013-03-09       Impact factor: 4.435

6.  Chronotropic incompetence and abnormal autonomic modulation in ambulatory Chagas disease patients.

Authors:  Ana Luiza Lunardi Rocha; Federico Lombardi; Manoel Otávio da Costa Rocha; Márcio Vinícius Lins Barros; Vladimir da Costa Val Barros; Adelina Martha Reis; Antonio Luiz Pinho Ribeiro
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-01       Impact factor: 1.468

7.  Pupillary Light Reflexes are Associated with Autonomic Dysfunction in Bolivian Diabetics But Not Chagas Disease Patients.

Authors:  Anthony Halperin; Monica Pajuelo; Jeffrey A Tornheim; Nancy Vu; Andrés M Carnero; Gerson Galdos-Cardenas; Lisbeth Ferrufino; Marilyn Camacho; Juan Justiniano; Rony Colanzi; Natalie M Bowman; Tiffany Morris; Hamish MacDougall; Caryn Bern; Steven T Moore; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2016-04-04       Impact factor: 2.345

Review 8.  Developments in the management of Chagas cardiomyopathy.

Authors:  Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-23

9.  Benzonidazole therapy modulates interferon-γ and M2 muscarinic receptor autoantibody responses in Trypanosoma cruzi-infected children.

Authors:  Romina A Cutrullis; Guillermo F Moscatelli; Samanta Moroni; Bibiana J Volta; Rita L Cardoni; Jaime M Altcheh; Ricardo S Corral; Héctor L Freilij; Patricia B Petray
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

10.  Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors.

Authors:  Antonio L Ribeiro; Ester C Sabino; Milena S Marcolino; Vera M C Salemi; Barbara M Ianni; Fábio Fernandes; Luciano Nastari; André Antunes; Márcia Menezes; Cláudia Di Lorenzo Oliveira; Vandana Sachdev; Danielle M Carrick; Michael P Busch; Eduard L Murphy
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.